The / allele of the ACE gene is associated with improved exercise capacity in women with McArdle disease

British Journal of Sports Medicine

Volumn 42, Issue 2, 2008, Pages 134-140

  Gomez Gallego F ^a   Santiago, C ^a   Moran M ^b   Perez M ^a   Mate Munoz J L ^a   Fernandez Del Valle M ^a   Rubio, J C ^b,c   Garcia Consuegra, I ^b,c   Foster, C ^d   Andreu, I A L ^c,e   Martin M A ^b   Arenas, J ^b   Lucia, Alejandro ^a  

^a UNIVERSIDAD EUROPEA DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^d UNIVERSITY OF WISCONSIN LA CROSSE   (United States)

^e HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ALLELE; ARTICLE; BICYCLE ERGOMETER; CLINICAL ARTICLE; CONTROLLED STUDY; EXERCISE; FEMALE; GENETIC ASSOCIATION; GENOTYPE; GLYCOGEN STORAGE DISEASE TYPE 5; GROSS MECHANICAL EFFICIENCY; HOMOZYGOTE; HUMAN; MALE; OXYGEN CONSUMPTION; PARAMETERS OF MEASUREMENT AND ANALYSIS; STATISTICAL SIGNIFICANCE; VENTILATORY THRESHOLD; ADOLESCENT; AGED; CASE CONTROL STUDY; EXERCISE TEST; EXERCISE TOLERANCE; GENETICS; HEART RATE; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADOLESCENT; ADULT; AGED; ALLELES; CASE-CONTROL STUDIES; EXERCISE; EXERCISE TEST; EXERCISE TOLERANCE; EXERTION; FEMALE; GENOTYPE; GLYCOGEN STORAGE DISEASE TYPE V; HEART RATE; HUMANS; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; PEPTIDYL-DIPEPTIDASE A;

EID: 39449090137     PISSN: 03063674     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjsm.2007.038992     Document Type: Article

References (33)

1. McArdle B. Myopathy due to a defect in muscle glycogen breakdown. Clin Sci 1951;10:13-33.
2. Tsujino S, Shanske S, DiMauro S. Molecular genetic heterogeneity of myophosphorylase deficiency (McArdle disease). N Engl J Med 1993;329:241-5.
3. Bruno C, Cassandrini D, Martinuzzi A, et al. McArdle disease: the mutation spectrum of PYGM in a large Italian cohort. Hum Mutat 2006;27:718.
4. Martin MA, Rubio JC, Buchbinder J, et al. Molecular heterogeneity of myophosphorylase deficiency (McArdle's disease): a genotype-phenotype correlation study. Ann Neurol 2001;50:574-81.
5. Rubio JC, Nogales-Gadea G, Garcia-Consuegra I, et al. A proposed molecular diagnosis flowchart for myophosphorylase deficiency (McArdle disease) in blood samples from Spanish patients. Hum Mutat 2007;28:203-4.
6. Martinuzzi A, Sartori E, Fanin M, et al. Phenotype modulators in myophosphorylase deficiency. Ann Neurol 2003;53:497-502.
7. Gayagay G, Yu B, Hambly B, et al. Elite endurance athletes and the ACE I allele: the role of genes in athletic performance. Hum Genet 1998;103:48-50.
8. Dragovic T, Minshall R, Jackman HL, et al. Kininase II-type enzymes. Their putative role in muscle energy metabolism. Diabetes 1996;45(Suppl 1):S34-7.
9. Woods DR, Humphries SE, Montgomery HE. The ACE I/D polymorphism and human physical performance. Trends Endocrinol Metab 2000;11:416-20.
10. Henriksen EJ, Jacob S. Effect of captopril on glucose transport activity in skeletal muscle of obese Zucker rats. Metabolism 1995;44:267-72.
11. Henriksen EJ, Jacob S, Kinnick TR, et al. ACE inhibition and glucose transport in insulin-resistant muscle: roles of bradykinin and nitric oxide. Am J Physiol Regul Integr Comp Physiol 1999;277: R332-6.
12. Jacob S, Henriksen EJ, Fogt DL, et al. Effects of trandolapril and verapamil on glucose transport in insulin-resistant rat skeletal muscle. Metabolism 1996;45:535-41.
13. Vissing J, Haller RG. The effect of oral sucrose on exercise tolerance in patients with McArdle's disease. N Engl J Med 2003;349:2503-9.
14. Lucia A, Maté-Muñoz JL, Pérez M, et al. Double Trouble (McArdle's disease and myasthenia gravis): how can exercise help? Muscle Nerve 2007;35:125-8.
15. Maté-Muñoz JL, Moran M, Pérez M, et al. Favorable responses to acute and chronic exercise in McArdle's patients. Clin J Sports Med 2007;17:297-303.
16. Pérez M, Martin MA, Rubio JC, et al. Exercise capacity in a 78 year old patient with McArdle's disease: it is never too late to start exercising. Br J Sports Med 2006;40:725-6.
17. Pérez M, Maté-Muñoz JL, Foster C, et al. Exercise capacity in a child with McArdle's disease. J Child Neurol 2007;22:880-2.
18. Pérez M, Morán M, Cardona C, et al. Can McArdle's patients run? A case report. Br J Sports Med 2007;41:53-4.
19. Lucia A, Hoyos J, Santalla A, et al. Tour de France vs Vuelta a España: Which is harder? Med Sci Sports Exerc 2003;35:872-8.
20. Chavarren J, Calbet JAL. Cycling efficiency and pedalling frequency in road cyclists. Eur J Appl Physiol Occup Physiol 1999;80:555-63.
21. Lucia A, Gómez-Gallego F, Chicharro JL, et al. Is there an association between ACE and CKMM polymorphisms and cycling performance status during 3-week races? Int J Sports Med 2005;26:442-7.
22. Giner V, Corella D, Chaves FJ, et al. Renin-angiotensin system genetic polymorphisms and essential hypertension in the Spanish population. Med Clin (Barc) 2001;117:525-9.
23. Spirduso WW. Physical dimensions of aging. Champaign, IL: Human Kinetics, 1997:95-121.
24. 2 during exercise in humans: the peak vs. maximum issue. J Appl Physiol 2003;95:1901-7.
25. Myers J, Prakash M, Froelicher V, et al. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 2002;4:793-801.
26. Pedersen BK, Saltin B. Evidence for prescribing exercise as therapy in chronic disease. Scand J Med Sci Sports 2006;16(Suppl 1):3-63.
27. Lauer MS, Okin PM, Larson MG, et al. Impaired heart rate response to graded exercise. Prognostic implications of chronotropic incompetence in the Framingham heart study. Circulation 1996;93:1520-6.
28. Wiens RD, Lafia P, Marder CM, et al. Chronotropic incompetence in clinical exercise testing. Am J Cardiol 1984;54:74-8.
29. Montgomery HE, Clarkson P, Dollery CM, et al. Association of angiotensin-converting enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training. Circulation 1997;5:741-7.
30. Hamroff G, Katz SD, Mancini D, et al. Addition of angiotensin II receptor blockade to maximal angiotensin-converting enzyme inhibition improves exercise capacity in patients with severe congestive heart failure. Circulation 1999;99:990-2.
31. Baarends EM, Schols AM, Akkermans MA, et al. Decreased mechanical efficiency in clinically stable patients with COPD. Thorax 1997;52:981-6.
32. Brooks GA, Butterfield GE, Wolfe RR, et al. Increased dependence on blood glucose after acclimatization to 4,300 m. J Appl Physiol 1991;70:919-27.
33. Wasserman K, Hansen JE, Sue DY, et al. Principles of exercise testing and interpretation. 4th edn. Philadelphia: Lea & Febiger, 2005:111-32.